<?xml version='1.0' encoding='UTF-8'?>
<PolymerNanocomposite><PDB_ID>4NZ2</PDB_ID><DATA_SOURCE><Citation><CitationType>research article</CitationType><Publication>Drug Discovery Today</Publication><Title>Structure-based ligand design to overcome CYP inhibition in drug discovery projects</Title><Author>Brändén, Gisela</Author><Author>Sjögren, Tove</Author><Author>Schnecke, Volker</Author><Author>Xue, Yafeng</Author><Publisher>Elsevier</Publisher><PublicationYear>2014</PublicationYear><DOI>10.1016/j.drudis.2014.03.012</DOI><Volume>19</Volume><Issue>7</Issue></Citation></DATA_SOURCE><MATERIALS><Matrix><MatrixComponent><ChemicalName>Cytochrome P450 2C9</ChemicalName><MacroMoleculeClass>OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR</MacroMoleculeClass><MacroMoleculeType>Protein</MacroMoleculeType><ManufacturerOrSourceName>Homo sapiens</ManufacturerOrSourceName><MolecularWeight><value>110919.84</value></MolecularWeight></MatrixComponent></Matrix></MATERIALS><CHARACTERIZATION><XRay_Diffraction_and_Scattering><Equipment>ESRF BEAMLINE ID23-1 ADSC QUANTUM 315r</Equipment><Description>Data collection temperature: 100 K, Resolution: 2.45</Description></XRay_Diffraction_and_Scattering></CHARACTERIZATION><PROPERTIES><Thermal><MeasurementMethod>VAPOR DIFFUSION</MeasurementMethod><CrystalizationTemperature><value>293</value><unit>Kelvin</unit></CrystalizationTemperature></Thermal><Biological><Sequence>MAKKTSSKGRPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIEILSSPWIQVYNNFPALLDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPVHHHH</Sequence><SpaceGroup>P 3 2 1</SpaceGroup><pH>8</pH></Biological></PROPERTIES></PolymerNanocomposite>